Safety and efficacy of topical, fixed‐dose combination calcipotriene (0.005%) and betamethasone (0.064% as dipropionate) gel in adolescent patients with scalp and body psoriasis: a...

por Eichenfield, L.F., Marcoux, D., Kurvits, M., Liljedahl, M.
Publicado 2020

Safety and efficacy of fixed‐dose combination calcipotriol (50 μg/g) and betamethasone dipropionate (0.5 mg/g) cutaneous foam in adolescent patients (aged 12 to <17 years) with pla...

por Seyger, M., Abramovits, W., Liljedahl, M., Hoejen, M.N., Teng, J.
Publicado 2020